During the past decade, Satakunnan keskussairaala conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Satakunnan keskussairaala" #1 sponsor was "Turku University Hospital" with 4 trials, followed by "Pfizer" with 3 trials sponsored, "Bayer" with 1 trials sponsored, "Birken AG" with 1 trials sponsored and "Medtronic Cardiac Rhythm and Heart Failure" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Satakunnan keskussairaala" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Finnbladder" with 1 trials as a collaborator and "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Satakunnan keskussairaala" are "Cancer of the Prostate" (2 trials), "Prostate Cancer" (2 trials), "Back Pain" (1 trials), "Bladder Cancer" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Satakunnan keskussairaala" in a lesser frequency.

Most popular intervention types in "Satakunnan keskussairaala" are "Drug" (8 trials), "Device" (3 trials), "Procedure" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Enzalutamide" (2 trials), "5-FU" (1 trials), "Bankart" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Satakunnan keskussairaala" are 8 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Satakunnan keskussairaala". 1 are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Satakunnan keskussairaala, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Satakunnan keskussairaala, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".

Satakunnan keskussairaala has several departments that took part in Clinical trials: "dep of physical medicine and rehabilitation Satasairaala" - 3 trials